There is an increasing interest in improving the understanding of pathophysiology, outcome measures, and therapies of rheumatic skin disease. Increasingly, studies are using the skin as a primary endpoint for evaluating therapies. This will review the current state of the art for the most common rheumatic skin diseases.
JT, C., VP, W., Clarke, J. T., & Werth, V. P. (2010). Rheumatic manifestations of skin disease. Current Opinion in Rheumatology, 22(1), 78–84. https://doi.org/10.1097/BOR.0b013e328333b9e2